Neurocrine Biosciences Financials

Values in thousands	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	$814,500	$805,500	$794,900	$687,500
Gross Profit	800,700	787,900	780,900	676,200
EBITDA	193,400	235,400	299,500	152,900
EBIT	186,100	227,900	291,800	145,600
Net Income	197,900	153,700	209,500	107,500
Net Change In Cash	814,500	805,500	794,900	687,500
Free Cash Flow	136,700	390,800	214,300	89,500
Cash	266,500	713,000	340,200	264,000
Basic Shares	103,400	102,500	102,500	101,000

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$2,860,500	$2,355,300	$1,887,100	$1,488,700
Gross Profit	2,808,400	2,321,300	1,847,400	1,465,500
EBITDA	666,600	639,700	416,100	264,600
EBIT	636,500	612,600	394,800	249,000
Net Income	478,600	341,300	249,700	154,500
Net Change In Cash	2,860,500	2,355,300	1,887,100	1,488,700
Cost of Revenue				-72,000
Free Cash Flow	748,700	557,200	361,600	322,900
Cash	713,000	233,000	251,100	262,900
Basic Shares	102,500	103,700	101,000	98,900